EQS-News: Unicycive Therapeautics, Inc. Unicycive’s Doug Jermasek, EVP-Corporate Development Discusses the Importance of Medication Compliance and the Issues with Pill Burden 08.11.2022 / 15:00 CET/CEST The issuer is solely responsible for the content of this announcement. Contact Details Anne Marie Fields - Stern Investor Relations +1 212-362-1200
[email protected] Company Website https://unicycive.com/ News Source: News Direct 08.11.2022 CET/CEST Dissemination of a Corporate News,...